Analyst firms · BofA Securities · TFX
BofA Securities TFX price target and rating history
Teleflex Incorporated (TFX) · Health Care
BofA Securities rates Teleflex Incorporated (TFX) Buy with a $158 price target, as of its latest action on Sep 28, 2026. It has published 4 rating actions on TFX since May 2022, including 2 upgrades and 1 downgrade. Across 7 firms with a TFX price target in the last 12 months, the median target is $155. BofA Securities's $158 is 2% above that.
- Current rating
- Buy
- Price target
- $158
- Median target, all firms
- $155
- Actions on TFX
- 4
BofA Securities price target on TFX
Every BofA Securities rating on TFX
- Sep 28, 2026
- Apr 13, 2026
- Mar 4, 2025
- May 9, 2022
How other firms rate TFX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| BofA Securities | Buy | $158 | Sep 28, 2026 |
| UBS | Neutral | $145 | Jul 28, 2026 |
| BMO Capital Markets | Outperform | $159 | Jul 9, 2026 |
| Piper Sandler | Overweight | $160 | Jun 8, 2026 |
| RBC Capital Markets | Outperform | $155 | May 8, 2026 |
| Raymond James | Outperform | $128 | Mar 27, 2026 |
| Needham | Buy | $138 | Jan 27, 2026 |
Questions about BofA Securities and TFX
- What is BofA Securities's price target for TFX?
- BofA Securities's latest stated price target for Teleflex Incorporated (TFX) is $158, from its action on Sep 28, 2026.
- What is BofA Securities's rating on TFX?
- BofA Securities rates TFX Buy, a bullish rating, as of Sep 28, 2026.
- When did BofA Securities last change its view on TFX?
- On Sep 28, 2026, BofA Securities upgrades to Buy from Neutral, price target $158.
- How does BofA Securities's TFX target compare with other analysts?
- Across 7 firms with a TFX price target in the last 12 months, the median target is $155. BofA Securities's $158 is 2% above that.
More TFX rating histories
All BofA Securities ratingsTFX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.